SynthesisFrontiers in cardiovascular medicine2022

Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis.

Luiz Sergio Fernandes de Carvalho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.